Wichtige Publikationen zur Mamma-MRT und Brustkrebs

1. AGO-Online - Mamma. Accessed 15 Apr 2023

2. Amornsiripanitch N, Bickelhaupt S, Shin HJ, et al (2019) Diffusion-weighted MRI for Unenhanced Breast Cancer Screening. Radiology 293:504–520.

3. Autier P, Boniol M, Koechlin A, et al (2017) Effectiveness of and overdiagnosis from mammography screening in the Netherlands: population based study. BMJ 359:j5224.

4. Bakker MF, de Lange SV, Pijnappel RM, et al (2019) Supplemental MRI Screening for Women with Extremely Dense Breast Tissue. N Engl J Med 381:2091–2102.

5. Bennani-Baiti B, Baltzer PA (2017) MR Imaging for Diagnosis of Malignancy in Mammographic Microcalcifications: A Systematic Review and Meta-Analysis. Radiology 283:692–701.

6. Bennani-Baiti B, Bennani-Baiti N, Baltzer PA (2016) Diagnostic Performance of Breast Magnetic Resonance Imaging in Non-Calcified Equivocal Breast Findings: Results from a Systematic Review and Meta-Analysis. PloS One 11:e0160346.

7. Benndorf M, Baltzer PAT, Vag T, et al (2010) Breast MRI as an adjunct to mammography: Does it really suffer from low specificity? A retrospective analysis stratified by mammographic BI-RADS classes. Acta Radiol Stockh Swed 1987 51:715–721.

8. Bouchardy C, Fioretta G, Verkooijen HM, et al (2007) Recent increase of breast cancer incidence among women under the age of forty. Br J Cancer 96:1743–1746.

9. Cancer of the Breast (Female) - Cancer Stat Facts. In: SEER.

10. Chiu SY-H, Duffy S, Yen AM-F, et al (2010) Effect of baseline breast density on breast cancer incidence, stage, mortality, and screening parameters: 25-year follow-up of a Swedish mammographic screening. Cancer Epidemiol Biomark Prev Publ Am Assoc Cancer Res Cosponsored Am Soc Prev Oncol 19:1219–1228.

11. Comstock CE, Gatsonis C, Newstead GM, et al (2020) Comparison of Abbreviated Breast MRI vs Digital Breast Tomosynthesis for Breast Cancer Detection Among Women With Dense Breasts Undergoing Screening. JAMA 323:746–756.

12. Frishberg BM (1994) The utility of neuroimaging in the evaluation of headache in patients with normal neurologic examinations. Neurology 44:1191–1197

13. Full-scale vs. Abbreviated Sequences in MR Mammography – the Best of Both Worlds.

14. Geuzinge HA, Obdeijn I-M, Rutgers EJT, et al (2020) Cost-effectiveness of Breast Cancer Screening With Magnetic Resonance Imaging for Women at Familial Risk. JAMA Oncol.

15. Gøtzsche PC, Nielsen M (2011) Screening for breast cancer with mammography. Cochrane Database Syst Rev CD001877.

16. Hatakenaka M, Soeda H, Yabuuchi H, et al (2008) Apparent diffusion coefficients of breast tumors: clinical application. Magn Reson Med Sci MRMS Off J Jpn Soc Magn Reson Med 7:23–29.

17. (2018) Jahresbericht Evaluation, Deutsches Mammographie-Screening-Programm.

18. Jarvik JG, Hollingworth W, Martin B, et al (2003) Rapid magnetic resonance imaging vs radiographs for patients with low back pain: a randomized controlled trial. JAMA 289:2810–2818.

19. Kaiser CG, Dietzel M, Vag T, Froelich MF (2020) Cost-effectiveness of MR-mammography vs. conventional mammography in screening patients at intermediate risk of breast cancer - A model-based economic evaluation. Eur J Radiol 109355.

20. Kaiser CG, Reich C, Dietzel M, et al (2015) DCE-MRI of the breast in a stand-alone setting outside a complementary strategy - results of the TK-study. Eur Radiol 25:1793–1800.

21. Kaiser WA (1989) Magnetresonanztomographie der Mamma. Erfahrungen nach 253 Untersuchungen.

22. Kaiser WA (2009) Signs in MR-Mammography, 1st ed. 2008. Corr. 2nd printing.

23. Kalager M, Adami H-O, Bretthauer M, Tamimi RM (2012) Overdiagnosis of invasive breast cancer due to mammography screening: results from the Norwegian screening program. Ann Intern Med 156:491–499.

24. Krebs - Brustkrebs.

25. Kuhl C (2007) The current status of breast MR imaging. Part I. Choice of technique, image interpretation, diagnostic accuracy, and transfer to clinical practice. Radiology244:356–378.

26. Kuhl CK, Strobel K, Bieling H, et al (2017) Supplemental Breast MR Imaging Screening of Women with Average Risk of Breast Cancer. Radiology 283:361–370.

27. Kuhl C, Weigel S, Schrading S, et al (2010) Prospective multicenter cohort study to refine management recommendations for women at elevated familial risk of breast cancer: the EVA trial. J Clin Oncol Off J Am Soc Clin Oncol 28:1450–1457.

28. Lee CH, Dershaw DD, Kopans D, et al (2010) Breast Cancer Screening With  Imaging: Recommendations From the Society of Breast Imaging and the ACR on the Use of Mammography, Breast MRI, Breast Ultrasound, and Other Technologies for the Detection of Clinically Occult Breast Cancer. J Am Coll Radiol 7:18–27.

29. M.Ali RMK, England A, McEntee MF, et al (2018) Effective lifetime radiation risk for a number of national mammography screening programmes. Radiography 24:240–246.

30. Mann RM, Kuhl CK, Kinkel K, Boetes C (2008) Breast MRI: guidelines from the European Society of Breast Imaging. Eur Radiol 18:1307–1318.

31. Monticciolo DL, Newell MS, Moy L, et al (2018) Breast Cancer Screening in Women at Higher-Than-Average Risk: Recommendations From the ACR. J Am Coll Radiol JACR 15:408–414.

32. New Global Cancer Data: GLOBOCAN 2018 | UICC.

33. Paci E, EUROSCREEN Working Group (2012) Summary of the evidence of breast cancer service screening outcomes in Europe and first estimate of the benefit and harm balance sheet. J Med Screen 19 Suppl 1:5–13.

34. Pisano ED, Hendrick RE, Yaffe MJ, et al (2008) Diagnostic accuracy of digital versus film mammography: exploratory analysis of selected population subgroups in DMIST. Radiology 246:376–383.

35. Radiology AC of (2016) ACR BI-RADS®-Atlas der Mammadiagnostik: Richtlinien zu Befundung, Handlungsempfehlungen und Monitoring.

36. Rahbar H, Partridge SC, Eby PR, et al (2011) Characterization of ductal carcinoma in situ on diffusion weighted breast MRI. Eur Radiol 21:2011–2019.

37. Riedl CC, Luft N, Bernhart C, et al (2015) Triple-modality screening trial for familial breast cancer underlines the importance of magnetic resonance imaging and questions the role of mammography and ultrasound regardless of patient mutation status, age, and breast density. J Clin Oncol Off J Am Soc Clin Oncol 33:1128–1135.

38. Sardanelli F, Aase HS, Álvarez M, et al (2017) Position paper on screening for breast cancer by the European Society of Breast Imaging (EUSOBI) and 30 national breast radiology bodies from Austria, Belgium, Bosnia and Herzegovina, Bulgaria, Croatia, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Israel, Lithuania, Moldova, The Netherlands, Norway, Poland, Portugal, Romania, Serbia, Slovakia, Spain, Sweden, Switzerland and Turkey. Eur Radiol27:2737–2743.

39. Sardanelli F, Boetes C, Borisch B, et al (2010) Magnetic resonance imaging of the breast: recommendations from the EUSOMA working group. Eur J Cancer Oxf Engl 1990 46:1296–1316.

40. Sardanelli F, Podo F, Santoro F, et al (2011) Multicenter surveillance of women at high genetic breast cancer risk using mammography, ultrasonography, and contrast-enhanced magnetic resonance imaging (the high breast cancer risk italian 1 study): final results. Invest Radiol 46:94–105.

41. (2020) S3-Leitlinie Mammakarzinom. 453.

42. Tabar L, Fagerberg G, Day NE, et al (1992) Natural history of breast cancer. Lancet Lond Engl 339:1108.

43. Tollens F, Baltzer PAT, Dietzel M, et al (2021) Cost-Effectiveness of MR-Mammography in Breast Cancer Screening of Women With Extremely Dense Breasts After Two Rounds of Screening. Front Oncol 11:724543.

44. Tollens F, Baltzer PAT, Dietzel M, et al (2022) Economic potential of abbreviated breast MRI for screening women with dense breast tissue for breast cancer. Eur Radiol.

45. Veenhuizen SGA, de Lange SV, Bakker MF, et al (2021) Supplemental Breast MRI for Women with Extremely Dense Breasts: Results of the Second Screening Round of the DENSE Trial. Radiology 203633.

46. Welch HG, Prorok PC, O’Malley AJ, Kramer BS (2016) Breast-Cancer Tumor Size, Overdiagnosis, and Mammography Screening Effectiveness. N Engl J Med 375:1438–1447.

47. Robert Koch-Institut (2021) Krebs in Deutschland für 2017/2018. 87-88.


Um unsere Website zu verbessern und Ihnen ein großartiges Website-Erlebnis zu bieten, nutzen wir auf unserer Seite Cookies und Trackingmethoden. In den Privatsphäre-Einstellungen können Sie einsehen, welche Dienste wir einsetzen und jederzeit, auch durch nachträgliche Änderung der Einstellungen, selbst entscheiden, ob und inwieweit Sie diesen zustimmen möchten.

Notwendige Cookies werden immer geladen